Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2014-04-28

Clinical Trial Update: Polycaprolactone / Tricalcium Phosphate (PCL/TCP) v Titanium Orbital Implant : Randomised Trial [Phase 2]

View source ↗

Summary

A randomized Phase 2 trial comparing a polycaprolactone/tricalcium phosphate orbital implant with a titanium orbital implant for fractures-associated enophthalm…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Polycaprolactone / Tricalcium Phosphate (PCL/TCP) Orbital Implant (polycaprolactone/tricalcium phosphate implant)
  • Titanium Orbital Implant (titanium orbital implant)

Snippet

Sponsor: National University Hospital, Singapore | Conditions: Fractures, Enophthalmos | Phase 2 | Status: UNKNOWN